ENOVIS CORPORATION
(NYSE: ENOV)

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

43.230

+1.960 (+4.75%)
Range 41.556 - 43.230   (4.03%)
Open 41.580
Previous Close 41.270
Bid Price 69.180
Bid Volume 8
Ask Price 69.200
Ask Volume 10
Volume 209,418
Value -
Remark
Delayed prices. Updated at 02 Nov 2024 00:27.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis